Synthesis of 2-thiouracil and 2-thiothymine peptide nucleic acid monomers compatible with fmoc-based oligomerization by Martin-Chan, Timothy
Western University 
Scholarship@Western 
Electronic Thesis and Dissertation Repository 
7-26-2018 10:45 AM 
Synthesis of 2-thiouracil and 2-thiothymine peptide nucleic acid 
monomers compatible with fmoc-based oligomerization 
Timothy Martin-Chan 
The University of Western Ontario 
Supervisor 
Hudson, Robert H.E. 
The University of Western Ontario 
Graduate Program in Chemistry 
A thesis submitted in partial fulfillment of the requirements for the degree in Master of Science 
© Timothy Martin-Chan 2018 
Follow this and additional works at: https://ir.lib.uwo.ca/etd 
 Part of the Organic Chemistry Commons 
Recommended Citation 
Martin-Chan, Timothy, "Synthesis of 2-thiouracil and 2-thiothymine peptide nucleic acid monomers 
compatible with fmoc-based oligomerization" (2018). Electronic Thesis and Dissertation Repository. 
5510. 
https://ir.lib.uwo.ca/etd/5510 
This Dissertation/Thesis is brought to you for free and open access by Scholarship@Western. It has been accepted 
for inclusion in Electronic Thesis and Dissertation Repository by an authorized administrator of 
Scholarship@Western. For more information, please contact wlswadmin@uwo.ca. 
iii 
  
Abstract 
Pseudo-complementary nucleobases are modified nucleobases which exhibit 
normal base pairing with unmodified complementary nucleobases; however, will not 
undergo stable base pairing with other pseudo-complementary nucleobases. The pseudo-
complementary nature of these bases is of interest for the synthesis of pseudo-
complementary peptide nucleic acid (pcPNA) oligomers, which are capable of binding 
targets in double-stranded DNA through a double duplex strand invasion. Until recently, 
pcPNAs were synthesized via Boc-based oligomerization chemistry which is currently less 
popular than the Fmoc-based strategy.  
This research describes the development of a Fmoc protected thiouracil PNA 
monomer with an acid labile protecting group for use in standard SPPS. The synthesis uses 
an orthogonal protection strategy where the nucleobase is deprotected under standard 
acidic deprotection and resin cleavage conditions, while oligomerization occurs under 
basic conditions.  
Keywords:  
Peptide nucleic acid, PNA, pseudo-complementary nucleic acid, pcPNA, double duplex 
invasion, thiouracil, protecting groups 
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Chapter 1: General introduction 
1.1. Discovery of DNA 
Nuclein, first isolated by Swiss doctor Friedrich Miescher from leukocytes in the 
pus on surgical bandages as early as 1868, became one of the most important discoveries 
in the fields of biochemistry and chemical biology. While studying the chemical 
composition of leukocyte cells, Miescher discovered a precipitate which was resistant to 
protease digestion, indicating the novel compound was neither a protein nor a lipid and 
was instead a new class of biological molecules.1 Miescher termed his discovery nuclein 
due to its extraction from the nucleus of the cells. Miesher’s discovery was later renamed 
as ‘nucleic acid’ due to its acidic properties.  
 In 1909, Phoebus Levene discovered the sugar, phosphate, and nucleobase 
components of deoxyribose nucleic acids (DNA), and identified four different 
nucleobases: adenine, thymine, cytosine, and guanine.2 However, it was not until the mid-
twentieth century with foundational discoveries in DNA research that the importance of 
nucleic acids in biological chemistry became clear. In 1944, Oswald T. Avery, Colin 
MacLeod and Maclyn McCarty proposed that nucleic acids were the carrier of genetic 
information, rather than protein which had long been believed.3 Research by Erwin 
Chargaff showed that purine and pyrimidine bases exist in a 1:1 ratio, demonstrating that 
the number of adenine bases equaled that of thymine and the number of guanine bases 
equaled that of cytosine.4-7 Finally, in 1953, working from x-ray analysis by Rosalind 
Franklin and Maurice Wilkins, James Watson and Frances Crick proposed the double 
helical structure of DNA and the mechanism by which hereditary information is copied.8  
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1.2. Nucleic acid chemistry 
Nucleic acids are an essential component of all known life, with DNA containing 
the hereditary information for all prokaryotes and eukaryotes. DNA contains a sugar-
phosphodiester backbone, composed of β-2-deoxyribose sugars combined by phosphate 
at the 3-to-5 hydroxyl of the sugars. Each sugar contains one of four nucleobases adenine, 
cytosine, guanine, or thymine attached to the C1 position of the sugar. Nucleic acid 
strands can undergo hybridization between complementary base pairs adenine and 
thymine, and cytosine and guanine to form a double stranded duplex. The hydrogen 
bonding pattern between nucleobases provides specificity of base pairing, with adenine 
forming two hydrogen bonds with thymine while cytosine forms three hydrogen bonds 
with guanine, preventing mismatched hybridization (Figure 1.1). The duplex is stabilized 
due to hydrophobic interactions between the nucleobases and hydrophilic interactions 
between the charged phosphate backbone and an aqueous environment, hydrogen 
bonding between complementary nucleobases, and π-stacking from the aromatic purine 
and pyrimidine nucleobases. Mismatched nucleobases destabilize the duplex, 
disfavouring hybridization from occurring, resulting in sequence specificity for strand 
hybridization. 
 The specificity resulting from base complementarity provides a foundation for the 
design of nucleic acid oligomers capable of specific hybridization with DNA or RNA targets, 
known as molecular probes. This specificity allows the design of nucleic acid probes for 
research and genetic screening, as well as potential design of nucleic acid based 
therapeutic agents which rely on high specificity targeting of a genetic sequence. 
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Oligonucleotide sequences provide the required specificity through base pairing between 
complementary nucleobases. This targeting of a specific genetic sequence can prevent 
undesired off-target effects.  
  
Figure 1.1. Base paring between nucleobases A) guanine and cytosine and B) adenine 
and thymine 
 
1.3. Modified nucleic acids and DNA analogs 
A major limitation to oligodeoxynucleotides (ODNs) used for in vivo applications 
results from the chemical instability of nucleic acid strands. ODN strands are susceptible 
to hydrolysis by nucleases, enzymes responsible for cleaving phosphodiester bonds in the 
breakdown of DNA and RNA, preventing ODNs from reaching the desired target. Many 
chemical modifications have been developed to increase the stability of the nucleic acid 
oligomers. In many cases, modifications to the sugar-phosphodiester backbone increase 
the stability in vivo as it prevents recognition and degradation by nucleases. Modification 
such as replacing the phosphate units with analogs such as phosphothioates or 
phosphoborates, or replacing the ribose sugar provide resistance to nucleases. However, 
these modifications often introduce chiral centers, and reduce the binding affinity 
between the oligomer and the target DNA or RNA strand.  
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1.4. Peptide nucleic acid chemistry 
One such backbone modification replaces the sugar-phosphodiester backbone 
with an aminoethyl glycine backbone with the nucleobases attached via a methylene 
carbonyl linker to form a peptide nucleic acid (PNA) (Figure 1.2.).9 The modified backbone 
is oligomerized through peptide bonds between a N-terminal amine, and a C-terminal 
carboxylic acid to form a PNA oligomer. Advantages of PNAs include, the aminoethyl 
glycine backbone maintains natural spacing observed with the sugar-phosphodiester 
backbone, allowing normal Watson-Crick base pairing with unmodified DNA, RNA and 
PNA strands. The unnatural backbone is resistant to degradation from either nucleases or 
proteases as the backbone is not recognized as either an oligonucleotide or a polypeptide 
for cleavage. The PNA oligomers undergo more stable hybridization with DNA and RNA 
than ODNs due to the neutral aminoethyl glycine backbone, ODNs experience anionic 
repulsion due to the negatively charged phosphate groups present in the backbone. 
Additionally, due to the neutral backbone, PNA hybridization is independent of ionic 
concentrations. PNAs have high sequence specificity for hybridization, with a single base 
mismatch significantly destabilizing a PNA-DNA duplex. The aminoethyl glycine backbone 
is achiral, allowing for easy synthesis of PNA monomers without difficult purification, and 
the amide bonds allow for easy oligomerization using standard solid phase peptide 
synthesis (SPPS) techniques. 
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Figure 1.2. Structure of deoxyribose nucleic acid oligomer (DNA), peptide nucleic acid 
oligomer (PNA) and amino acid oligomer (peptide) 
 
1.5. Peptide nucleic acids as therapeutic agents and molecular probes 
PNA oligomers have potential applications in the design of gene targeting 
therapeutic agents. These therapeutic agents typically target a mRNA sequence; 
hybridization with the target mRNA inhibits translation preventing protein synthesis, 
known as the antisense strategy. Alternatively, gene therapeutic agents can be designed 
to specifically recognize and hybridize a target gene, thereby inhibiting transcription and 
preventing gene expression (antigene strategy). Studies of PNA oligomers have shown 
potential for applications as both antisense and antigene therapeutic agents, 
demonstrating the ability to inhibit both translation and transcription.  
Antisense inhibition using PNA oligomers has been demonstrated to reduce 
translation in in vitro experiments. Inhibition occurs through steric blocking of translation 
which occurs either through hybridization overlapping the AUG start codon blocking 
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assembly of the ribosome complex at the start codon or through triplex formation with 
the coding region, arresting elongation resulting in the formation of truncated peptide.10-
12 The limitation of PNA based antisense therapies is that hybridization with target mRNA 
does not activate ribonuclease H (RNase H) -mediated cleavage of the RNA transcript, 
which is a more effective method of antisense inhibition. RNase H is an endonuclease 
enzyme which cleaves an RNA target using DNA (or a DNA analog) as a template causing 
inhibition of mRNA translation.13, 14 RNase H catalyzes the hydrolysis of the target RNA 
which is more efficient inhibition compared to steric blocking of the mRNA transcript 
which requires a 1:1 ratio of PNA:mRNA to inhibit expression. Unlike some 
oligonucleotide analogs such as phosphorothioates,15 PNA:RNA hybridization causes a 
structural change which is not recognized by the RNase H enzyme, limiting its 
effectiveness as an antisense gene therapy.  
Antigene therapies involve the invasion of the DNA duplex using an 
oligonucleotide analog to hybridize to the target gene and sterically block the function of 
RNA polymerase. In vitro studies suggest that PNA oligomers are capable of inhibiting 
transcriptional expression of both prokaryotic and eukaryotic RNA polymerase by 
hybridizing to either the gene promoter region or downstream of the promoter blocking 
RNA polymerase from accessing the template DNA strand.16, 17 Hybridization to the 
promoter region inhibits RNA expression by sterically blocking assembly of the RNA 
polymerase complex to the gene, while triplex invasion downstream of the promoter 
sterically blocks the progression of RNA polymerase, arresting transcription and resulting 
in the formation of truncated RNA transcripts. PNA oligomers have demonstrated 
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potential as antigene therapies, however PNA invasion of a DNA duplex requires the 
formation of a PNA2:DNA triplex for invasion to occur limiting targets to homopurine 
sequences, which can undergo Watson-Crick and Hoogsteen base pairing. Furthermore, 
triplex formation is kinetically slow at physiological salt conditions, limiting PNA2:DNA 
triplex hybridization.18 
1.6. PNA hybridization 
The stability of oligonucleotide duplexes can be determined as a measure of the 
thermal stability of the duplex. The thermal melting temperature (Tm) is defined as the 
temperature at which 50 % of the oligonucleotide duplex has dissociated. The Tm of 
oligonucleotides can be easily measured spectroscopically, due to the hypochromatic 
effect observed during hybridization. Free nucleobases absorb strongly around 260 nm, 
upon hybridization base pairing causes a reduction in the nucleobase absorbance.19 This 
change in absorbance allows easy determination of Tm values, using absorption 
spectroscopy, which is a convenient method of analyzing relative oligonucleotide duplex 
stability. Typically, PNA-DNA duplexes have higher Tm values compared to a DNA-DNA 
duplex of identical sequence, while a PNA-PNA duplex has a higher Tm than the PNA-DNA 
duplex, resulting in a relative duplex stability: PNA-PNA>PNA-DNA>DNA-DNA.  
The stability of the PNA-DNA duplex over the DNA-DNA duplex results from 
reduced electrostatic repulsion from the neutral aminoethyl glycine backbone, compared 
to the phosphate diester backbone. Thermodynamic studies of PNA-PNA and PNA-DNA 
hybridization show the lack of charged backbone typically results in more favourable 
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enthalpies of hybridization for the formation of PNA-PNA and PNA-DNA duplexes 
compared to the formation of a DNA-DNA duplex. In the case of PNA-DNA hybridization, 
a significant entropic contribution results from reduced ion association with the duplex 
backbone. The polyanionic phosphodiester backbone of DNA associates with Na+ and K+ 
counterions, while the neutral aminoethyl glycine backbone of PNA does not require 
counterions. Therefore, the reduced number of counterions associated with the PNA-
DNA hybrid compared to the DNA-DNA duplex increases the disorder of the system, giving 
a more favourable entropic contribution. Circular dichromism (CD) spectroscopy shows 
helices formed by PNA-DNA hybridization closely resembles the B-helix formed by DNA-
DNA hybridization suggesting hydrophobic interactions contribute to the stabilization of 
the PNA-DNA duplex. In contrast, CD spectroscopy of the PNA-PNA hybridization shows a 
rearrangement in the helical structure of the duplex, resulting in a more farourable 
enthalpic value, as a result of reduced electrostatic repulsion.18, 20, 21 
1.7. DNA strand invasion 
A major limitation of PNAs for many biological applications involving gene 
targeting is that PNA oligomers do not undergo duplex invasion of a double stranded DNA 
duplex. During duplex invasion, the displaced complementary strand remains bound 
upstream and downstream of invasion complex, thus the entropic benefit of replacing the 
anionic DNA strand with a neutral PNA strand is not obtained which decreases the free 
energy of hybridization making strand invasion unfavourable. One method to overcome 
this entropic restriction is to hybridize a complementary PNA oligomer to both strands of 
the complementary DNA duplex, thereby maximizing the enthalpic contribution from 
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strand hybridization. Lowering the energy of the invaded complex allows duplex invasion 
to occur in a process known as a double duplex invasion (Figure 1.3.). However, the 
double duplex invasion using PNA oligomers is hindered by the strong hybridization of 
PNAs, which results in highly stable PNA-PNA hybridization which is more favourable than 
PNA-DNA hybridization. As a result, the use of complementary PNA oligomers in a double 
duplex invasion, instead results in the formation of a stable PNA-PNA duplex leaving the 
target DNA duplex intact. 
 
Figure 1.3. Modes of hybridization between PNA oligomer and nucleic acid duplex 
 
A method of destabilizing the PNA-PNA duplex was developed by Nielsen et al22 
which utilized modified pseudo-complementary nucleobases to synthesis selectively 
binding oligomers, or pseudo-complementary PNAs (pcPNA). Pseudo-complementary 
nucleobases (Figure 1.4.), first reported by Gamper et al23 in DNA oligomers, are modified 
complementary nucleobases which, when paired with an unmodified complementary 
Triplex Triplex Invasion Duplex Invasion Double Duplex Invasion 
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nucleobase undergo normal base pairing; however, when combined with another 
pseudo-complementary nucleobase steric hinderance prevents normal base pairing. The 
pseudo-complementary nucleobases are synthetic analogs of adenine and thymine, 2,4-
diaminopurine (D) and 2-thiothymine (ST) respectively, which in combination form 
pseudo-complementary base pairs. D, an analog of adenine containing an additional 
exocyclic amine at the 2 position, undergoes base pairing with thymine forming a more 
stable base pairing compared to A:T due to additional hydrogen bonding from the 2 
position amine. ST, an analog of thymine which replaces the 2-position carbonyl with a 
thiol, undergoes normal base pairing with an unmodified adenine base. D:ST base pairing 
is destabilized due to steric hinderance between the 2-position exocyclic amine on D and 
the larger sulfur atom which replaces oxygen in ST. Nielsen et al22 reported the first 
synthesis of pcPNA oligomers using a boc-based SPPS approach and demonstrated their 
ability to undergo a double duplex invasion of a target DNA duplex.  
11 
  
 
Figure 1.4. Base pairing of natural and pseudo-complementary nucleobases A) adenine 
and thymine, B) diaminopurine and thymine, C) adenine and thiothymine, D) 
diaminopurine and thiothymine 
 
1.8. Solid phase peptide synthesis and protecting group strategy 
Two methods of SPPS have primarily been used for chemical oligomerization in 
peptide synthesis, which primarily differ in the protecting group strategy. All amino acids 
contain both a carboxylic acid and an amine, which undergo a condensation reaction to 
form an amide linkage during oligomerization, which must be protected and require 
different deprotection conditions for control of sequence specific oligomerization. In 
addition, many amino acids contain reactive sidechains which require separate functional 
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group protection. Similarly, PNAs contain both a carboxylic acid and a primary amine 
which require separate protection and deprotection strategies, with most nucleobases 
requiring further protection during oligomerization. Historically, peptide synthesis was 
performed using a gradient acidolysis protection strategy where N-terminal boc-
deprotection occurred under relatively weak acidic conditions, while C-terminal 
deprotection requires relatively stronger acidic conditions. This strategy for peptide 
synthesis was originally developed by Bruce Merrifield using a solid support resin for 
peptide synthesis,24, 25 for which he was awarded the 1984 Nobel Prize in chemistry. 
Advances in chemical synthesis lead to the development of an orthogonal protection 
strategy with N-terminal fmoc group for which deprotection occurs under weakly basic 
conditions and C-terminal deprotection occurring under weakly acidic conditions. This 
strategy results in higher yielding oligomerization, and as a result can be used to 
synthesize longer peptide sequences. Both strategies have been modified for standard 
PNA oligomerization, with the standard monomers commercially available for synthesis 
 The original synthesis of PNA oligomers was reported by Egholm, Buchardt, 
Nielsen and Berg in 199226 which utilized a tert-butyloxycarbonyl group on the terminal 
amine, while the C-terminus of the oligomer was attached to a solid support, typically a 
cross-linked polystyrene resin. The nucleobases were protected using acid labile 
protecting groups so oligomer deprotection could occur concurrently with resin cleavage, 
under strongly acidic conditions. Thymine requires no protection as it is unreactive under 
oligomerization conditions, while the exocyclic amines on cytosine, adenine and guanine 
are protected using a carboxybenzyl (cbz) protecting group.9, 26, 27 During monomer 
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synthesis, the C-terminal carbonyl is protected using a alkyl ester protecting group to 
prevent coupling between aminoethyl glycine molecules and to improve solubility in 
organic solvents.28 The Nα-boc protection is typically removed by treatment with 
trifluoroacetic acid (TFA), freeing the N-terminus for oligomerization from C-terminus to 
N-terminus. Oligomerization uses a coupling reagent such as hydroxybenzotriazole 
(HOBt) and N,N’-dicyclohexylcarbodiimide (DCC) which reacts with the carboxylic acid to 
form an active ester for amide bond formation. Post-synthesis treatment of the resin with 
hydrofluoric acid (HF) or trifluoromethylsulfonic acid (TFMSA) is used to cleave the 
synthesized oligomer from the solid support and to remove the cbz and bn protection of 
the nucleobases (Figure 1.5.).  
Figure 1.5. SPPS cycle for oligomerization with boc/cbz based protecting strategy 
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 The limitation of boc-based peptide synthesis results from the gradient protection 
strategy. This can result in undesired cleavage of the PNA oligomer from the solid support 
resin, lowering the yield of oligomer synthesis. Low yielding oligomerization limits the 
maximum length of oligomer synthesis. Additionally, the final deprotection and resin 
cleavage requires strongly acidic treatment with hydrofluoric acid which can damage the 
oligomer and the harsh reagents can be dangerous to work with. An orthogonal 
protection strategy which uses a fluorenylmethyloxycarbonyl (fmoc) protecting group on 
the terminal amine, which requires weakly basic conditions for deprotection. Typical 
deprotection conditions use a solution of 20 % v/v piperidine solution in 
dimethylformamide to remove the fmoc protection, for oligomerization on the N-
terminal (Figure 1.6.). The fmoc protecting group allows the use of more acid labile 
protecting groups for the C-terminal and for nucleobase protection. An acid labile linker 
is used to attach the polystyrene resin to the C-terminal of the oligomer. Nucleobase 
protection uses a more acid labile boc or benzhydryloxycarbonyl (bhoc) group to protect 
the exocyclic amines on cytosine, adenine, and guanine allowing resin cleavage and the 
final deprotection of the oligomer to be performed using a solution of 95 % v/v 
trifluoroacetic acid and 5 % triethylsilane as a cation scavenger. This orthogonal 
protection strategy uses milder deprotection conditions, and typically results in higher 
yielding oligomerization compared to the boc-based protection strategy. Due to these 
advantages, the fmoc-based protection strategy has become the standard for the 
chemical synthesis of peptides and PNA oligomers. 
15 
  
 
Figure 1.6. SPPS cycle for oligomerization with fmoc/boc based protection strategy 
 
The pcPNA synthesis developed by Nielsen et al utilized the boc-based protection 
strategy, which at the time of development was the standard for peptide synthesis. 
Advances in peptide synthesis have limited the use of pcPNAs in nucleic acid research due 
to the undesirable method of oligomerization. However, several applications have been 
developed which demonstrates the potential for pcPNAs and the need for further 
research. Until recently,29 only the boc-based SU monomer had been synthesized while 
both the boc protected and fmoc protected30 D monomers, therefore the focus of this 
research is to synthesize a fmoc protected SU monomer compatible with standard fmoc-
based SPPS.  
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1.9. Goals of thesis 
 Until recently, the synthesis of pcPNA oligomers was carried out using boc-based 
oligomerization strategy which has become unfavourable due to harsh deprotection 
conditions which result in lower yielding reactions thus limiting oligomer length. 
Therefore, the primary aim of this work is to develop a highly acid labile protecting group 
for thiouracil so that the PNA monomer is compatible with fmoc-based PNA 
oligomerization (Figure 1.7.). The 4-methoxybenzyl protecting group first used for boc-
based synthesis was reportedly removed upon treatment with TFMSA or HF used for resin 
cleavage and final deprotection. To improve the lability of the protecting group, electron 
donating groups will be added to the benzyl based protecting group and the acidolysis of 
the protecting group tested under milder deprotection conditions.  
 
  
Figure 1.7. Proposed synthesis of highly acid labile protecting group for thiouracil PNA 
monomer  
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Chapter 2: Highly acid labile S-protection of thiouracil and thiothymine 
2.1. Introduction 
 The oligomerization of peptide nucleic acids (PNAs) was designed based on the 
existing standard for peptide synthesis.1 At the time of development, standard solid phase 
peptide synthesis (SPPS) utilized gradient acidolysis, with relatively weakly acidic 
conditions removing N-terminal amine protection and stronger acidic conditions utilized 
for sidechain deprotection and cleavage from the solid support resin. Typically, thymine 
and uracil nucleobases do not require protection as there they do not contain nucleophilic 
exocyclic amino groups. However, replacing the carbonyl group of T and U with a thionyl 
group at the 2 position of the nucleobase creates a nucleophilic site. Unlike with T and U 
nucleobases, the thiol at the 2 position of 2-thiouracil (SU) is the most nucleophilic site 
due to the greater nucleophilicity of sulfur compared to nitrogen, as a result alkylation of 
the unprotected nucleobase with the methylene carbonyl linker results in S-alkylation 
rather than the desired N 1-alkylation. Therefore, protection of the SU nucleobases in 
necessary due to the nucleophilicity of the thiol group. 
Nielsen et al developed the synthesis of a protected thiouracil (SU) compatible 
with PNA oligomerization under standard SPPS conditions.2 This synthesis reports a 4-
methoxybenzyl protecting group on the 2-thiol position of the nucleobase, converting the 
thiol (1) to a thioether (2), which is removed under strongly acidic conditions used for 
global deprotection. The protected thiouracil nucleobase (3) is then attached to the 
protected aminoethyl glycine (AEG) backbone via a methylene carbonyl linker to yield the 
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SU monomer for oligomerization (Scheme 2.1.). The SU monomer is then incorporated 
into PNA oligomers using standard boc-based SPPS procedures. 
 
Scheme 2.1. Synthesis of thiouracil PNA monomer compatible with boc-based peptide 
synthesis2 
 
Modern SPPS techniques utilize an orthogonal protection system which removes 
protecting groups and cleaves the peptide from the solid support resin under milder acidic 
conditions. Due to the mild conditions used for global deprotection, this work aims to 
develop a more acid labile protecting strategy for the SU monomer which is easily 
removed under these conditions. The electron donation from the 4-methoxy substituents 
on the benzyl protecting group helps stabilize the carbocation formed from acidolysis of 
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the protecting group. We propose that increasing the electron donation into the benzylic 
position will increase the stability of the cleaved product (Figure 2.1.). The increased 
stabilization of the cationic product results in a more acid labile protecting group which 
can be removed under milder acidolysis conditions. This chapter focuses on the 
protection of the thiouracil nucleobase using an increased number of methoxy groups on 
the aromatic ring to tune the removal of the benzyl protecting group for fmoc-based 
synthesis. 
 
Figure 2.1. Mechanism of thiol protecting group acidolysis 
 
2.2. Synthesis 
2.2.1. Thiouracil protection with 2,4,6-trimethoxybenzyl group 
 The 4-methoxybenzyl protecting group used by Nielsen et al., was initially 
replaced by a 2,4,6-trimethoxybenzyl group for protection of the thiol group. Synthesis 
(Scheme 2.2.) started with 2,4,6-trimethoxybenzaldehyde (7) which was reduced using 
sodium borohydride, to yield 2,4,6-trimethoxybenzyl (8) alcohol as the product. The 
benzyl alcohol was then halogenated to replace the alcohol group with a good leaving 
group for addition onto the thiouracil nucleobase. Initial attempts at halogenation used 
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thionyl chloride as a chlorinating agent, however instability of the 2,4,6-trimethoxybenzyl 
chloride resulted in rapid decomposition of the intermediate, preventing addition to the 
nucleobase. The electron donation from the three methoxy substituents on the benzyl 
group greatly increases the electron density at the benzylic position which stabilizes the 
carbocation formed from the elimination of the benzylic chloride. However, the electron 
donation to the benzylic carbocation allows the rapid decomposition of the 2,4,6-
trimethoxybenzyl chloride upon workup of the reaction, preventing the isolation of the 
desired intermediate for the protection of the thiouracil nucleobase. 
 To overcome the issue with the workup and isolation of the 2,4,6-
trimethoxybenzyl chloride from the solution of thionyl chloride, a different chlorination 
method was utilized which did not require workup prior to addition of thiouracil. The 
2,4,6-trimethoxybenzyl alcohol was added to a solution of triphenylphosphine (Ph3P) and 
N-chlorosuccinimide as the chlorinating agent for the 2,4,6-trimethoxybenzyl alcohol. The 
solution was then added to a basic solution of thiouracil without workup of the reactive 
2,4,6-trimethoxybenzyl chloride intermediate (9). This enabled the synthesis of the 2,4,6-
trimethoxybenzyl protected SU nucleobase (10), however the reaction resulted in low 
yields of the desired product and triphenylphosphine oxide (Ph3PO) was a major 
byproduct of the reaction which could not be easily separated from the desired product. 
Due to the difficulty in purification, alkylation of the protected thiouracil was performed 
using the crude mixture of the nucleobase and Ph3PO. We believed that the 
triphenylphosphine oxide would not affect the alkylation of the nucleobase, and that once 
alkylated the thiouracil could be easily separated from the triphenylphosphine oxide by 
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column chromatography. The crude mixture reacted with methyl bromoacetate as the 
alkylating agent in a solution of sodium carbonate in dimethylformamide, and the 
resulting product (11) was purified by column chromatography. 
 
Scheme 2.2. Attempted synthesis of 2,4,6-trimethoxybenzyl protected thiouracil 
nucleobase 
 
 1H NMR analysis of the purified product indicated addition of the 2,4,6-
trimethoxybenzyl protection to the thiol group, however the 1H NMR spectra also 
indicated a loss of symmetry in the protecting group, with the detection of 3 distinct 
signals from the methoxy substituents on the aromatic ring. Furthermore, the integration 
of the aromatic protons on the benzyl ring decreased from 2 H to 1 H, suggesting a 
substitution on the aromatic ring. The low-resolution mass spectra of identified a 
compound with a molecular mass of 414.09 amu, which is about 34 amu larger than then 
expected mass of the compound (380.10 amu). Based on the mass of the synthesized 
compound, and the loss of symmetry in the 2,4,6-trimethoxybenzyl protecting group 
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suggest that chlorination of the aromatic ring had occurred in addition to chlorination of 
the benzylic carbon. A search of the literature found metal-free electrophilic aromatic 
halogenation of electron rich aromatic rings using N-halosuccinimide (NXS) as a 
halogenating agent, and catalytic trimethylsilyl chloride (TMSCl).3 The proposed 
mechanism for this reaction suggests that a small amount of chloride ions dissociate from 
TMSCl and reacts with NXS to form a diatomic interhalogen molecule which acts as the 
halogenating agent. This demonstrates the aromatic ring, when activated by electron 
donating groups, can undergo halogenation with N-halosuccinimide as a halogenating 
agent. Similarly, the highly electron rich aromatic ring of the 2,4,6-trimethoxybenzyl 
group undergoes a metal-free electrophilic aromatic halogenation from the N-
chlorosuccinimide and triphenylphosphine chlorination conditions.  
HMBC NMR analysis of the compound was performed to determine the structure 
of the synthesized compound. Three possible constitutional isomers exist from alkylation 
of the protected SU nucleobase, with alkylation of either the N-1 position or the N-3 
position common with alkylation of uracil and O-alkylation of the carbonyl at the 4-
position also possible. Analysis of the HMBC NMR spectra looks at interactions between 
the methylene carbonyl protons with the carbon atoms of the thiouracil ring. For the 
desired N-1 alkylation, the expected interaction would be observed with the C-2 and C-6 
atoms while N-3 alkylation would result in interaction between the methylene carbonyl 
protons and the C-2 and C-4 atoms. Neither of these outcomes are observed in the HMBC 
NMR spectra, instead interactions between the methylene carbonyl protons and the C-4 
and C-5 atoms indicating O-alkylation of the thiouracil. Due to the low yield of S-alkylation 
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of the thiouracil with the 2,4,6-trimethoxybenzyl protecting group, the subsequent 
halogenation of the electron rich aromatic ring of the benzyl group, and the difficulty in 
alkylating the N-1 position, a less electron donating group was used for the thiol 
protection. 
2.2.2. Thiouracil protection with 2,4-dimethoxybenzyl group 
The destabilizing effect from the electron donation of the three methoxy groups 
into the benzylic carbon on the 2,4,6-trimethoxybenzyl chloride can be reduced by 
removing one of the methoxy substituents from the aromatic ring, instead using the 2,4-
dimethoxybenzyl chloride. However, reducing the electron donation into the benzylic 
carbon will reduce the acid lability of the protecting group, as it reduces the stabilization 
of the carbocation formed from protecting group acidolysis. The 2,4-dimethoxybenzyl 
protecting group was used for protection of the nucleobase, as this would provide a more 
stable chloride intermediate than the 2,4,6-trimethoxybenzyl chloride, but would also 
provide more electron donation than the 4-methoxybenzyl group allowing easier 
acidolysis. 
 The protected thiouracil nucleobase was synthesized (Scheme 2.3.) starting with 
2,4-dimethoxybenzaldehyde (12), which was first reduced using sodium borohydride in 
methanol to yield the 2,4-dimethoxybenzyl alcohol (13). The benzyl alcohol is then 
halogenated using a solution of thionyl chloride to form 2,4-dimethoxybenzyl chloride 
(14). The reaction was quenched using aqueous sodium bicarbonate, then the 2,4-
dimethoxybenzyl chloride was extracted in ether to yield the compound as a clear 
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colourless oil. The 2,4-dimethoxybenzyl group was then added to the thiol group of the 
thiouracil using triethylamine as the base, which yielded the 2-(2,4-
dimethoxybenzyl)thiouracil (15) as a white solid. The protected thiouracil was then 
alkylated using methyl bromoacetate in a solution of sodium methoxide, which yielded a 
mixture containing both N-1-alkylation (16) and O-4-alkylation of the nucleobase which 
was easily separated by column chromatography. The N-1-alkylated product was 
synthesized in just a 22 % yield, while the O-alkylated product resulted in a 13 % yield. 
Despite the low yield of the synthesis, the unreacted S-(2,4-dimethoxybenzyl)thiouracil 
was easily separated by column chromatography and reacted with methyl bromoacetate 
and sodium methoxide in a second alkylation reaction to increase the yield of the desired 
N-1-alkylated product.  
 
Scheme 2.3. Synthesis of 2,4-dimethoxybenzyl protected thiouracil nucleobase 
 
The N-1- and O-alkylated constitutional isomers were characterized with 1H NMR 
spectroscopy. A comparison of the spectra showed similar chemical shifts with the 
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methylene carbonyl proton shifts as the major identifying feature of the constitutional 
isomers. The alkylation of the O-4 resulted in a downfield shift in the methylene carbonyl 
signals compared to alkylation at the N-1 position. Further HMBC NMR analysis of the 
compound suggested N-1 alkylation due to the interaction between the methylene 
carbonyl protons and the carbon atoms at the 2 and 5 positions of the pyrimidine ring, 
while the O-alkylation product showed coupling between the methylene carbonyl 
protons and the C-4 atom on the pyrimidine ring (Figure 2.2.).  
 
Figure 2.2. HMBC NMR interactions of methylene carbonyl protons with pyrimidine ring 
carbons when alkylated in the N-1, N-3 and O-4 positions 
 
The acid cleavage of the thiol protecting group was confirmed under standard 
deprotection conditions used for global deprotection of PNA oligomers synthesized using 
fmoc-based oligomerization. The N-1-alkylated S-(2,4-dimethoxybenzyl)thiouracil was 
mixed with a solution of 5 % triethylsilane in trifluoroacetic acid, then the acid was 
evaporated under a nitrogen stream then the product was triturated with ether. The 1H 
NMR spectra of the obtained product shows removal of the thiol protecting group under 
standard deprotecting conditions. The removal of the 2,4-dimethoxybenzyl group is seen 
as the absence of the methoxy protons, the aromatic benzyl protons and the benzylic 
protons in the NMR spectra. This test confirmed the acid lability of the thiol protecting 
group under standard deprotection conditions suggesting that once incorporated into a 
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PNA oligomer, using fmoc-based chemistry, the thiouracil nucleobases could be easily 
deprotected during the global deprotection and resin cleavage of the PNA oligomer.  
2.2.3. Thiouracil protection with 2-methyl-4-methoxybenzyl group 
 Recently published work reports the synthesis of a thiouracil monomer 
compatible with fmoc-based oligomerization conditions using a 2-methyl-4-
methoxybenzyl group for protection of the nucleobase.4 Electron donation from the 
methyl group into the aromatic ring, through hyperconjugation, increased electron 
density at the benzylic position which stabilizes the benzylic carbocation. The 
hyperconjugation of the methyl group provides weaker electron donation than the 
resonance from the methoxy groups; however, the electron donation from the methyl 
substituent combines with the electron donation of the para methoxy substituent to 
increase electron density at the benzylic position compared to the 4-methoxybenzyl 
group. Therefore the 2-methyl-4-methoxybenzyl protected SU nucleobase was 
synthesized (Scheme 2.4.) following the procedures described by Kittaka et al.4 in order 
to test the rate of the protecting group acidolysis compared to the rate of acidolysis of 
the newly synthesized 2,4-dimethoxybenzyl protected nucleobase.  
 The 2-methyl-4-methoxybenzyl aldehyde (17) was reduced to the benzyl alcohol 
(18) using sodium borohydride. The alcohol was then substituted with a chloride using 
thionyl chloride to yield the 2-methyl-4-methoxybenzyl chloride (19) for the protection of 
thiouracil. The benzyl group was added to the thiol group under basic conditions to yield 
the S-(2-methyl-4-methoxybenzyl)thiouracil (20) which was N-1 alkylated (21) with ethyl 
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bromoacetate using a solution of sodium ethoxide in ethanol. Under these conditions, the 
O-alkylated product was formed as the minor product, and the products were easily 
separated by column chromatography. 1H NMR analysis of the product matched the 
literature spectra reported by Kittaka et al., therefor no further characterization was 
performed.4  
 
Scheme 2.4. Synthesis of 2-methyl-4-methoxybenzyl protected thiouracil nucleobase 
 
2.2.4. Thiouracil protection with 4-methoxybenzyl group 
 To study the effects of the addition of methoxy substituents to the ortho- and 
para- positions of the benzene ring on the kinetics of the acidolysis of the benzyl 
protecting group from the thiol of the thiouracil nucleobase, the 4-methoxybenzyl 
protected thiouracil was synthesized. The 4-methoxybenzyl thiouracil being used in the 
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original synthesis of the thiouracil monomer for boc-based oligomerization, it was 
synthesized as a comparison for the more highly acid labile thiol protected monomers.  
 The S-(4-methoxybenzyl)thiouracil was synthesized (Scheme 2.5.) starting with 
the 4-methoxybenzyl alcohol (22), which was reduced to the benzyl alcohol (23) using 
sodium borohydride. The benzylic alcohol was substituted with chloride using thionyl 
chloride, and the resultant 4-methoxybenzyl chloride (24) was added to the thiouracil 
under basic conditions to obtain S-(4-methoxybenzyl)thiouracil (2). The protected 
nucleobase was then alkylated using ethyl bromoacetate and sodium ethoxide to yield N-
1 alkylated 4-methoxybenzyl protected thiouracil nucleobase (3). The 1H NMR spectra of 
the product matched the literature spectra reported by Nielsen et al.2 
 
Scheme 2.5. Synthesis of 4-methoxybenzyl protected thiouracil nucleobase 
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2.2.5. 4-Methoxybenzyl protected thiothymine 
 Thymine and uracil are nucleobases which differ only in the substituent at the 5-
position of the pyrimidine ring, and both undergo complementary base pairing with 
adenine. To date, only the thiouracil nucleobase has been studied as a pseudo-
complementary nucleobase in PNA oligomers; however, pseudo-complementary base 
pairing was first demonstrated using thiothymidine as a thymine analog in combination 
with 2,4-diaminopurine in oligodeoxynucleotides.5 Studies comparing the melting 
temperatures of oligodeoxynucleotides containing either thymine or uracil as the 
complementary base with adenine show an increased hybridization stability of 
oligodeoxynucleotides containing thymine compared to the stability of those containing 
uracil.6 To study to effect of thiothymine on the hybridization stability when incorporated 
into pcPNA oligomers, a protected thiothymine monomer was synthesized (Scheme 2.6.). 
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Scheme 2.6. Synthesis of 4-methoxybenzyl protected thiothymine nucleobase 
 
Thiothymine was synthesized from the thymine nucleobase by first methylating 
the N-1 and N-3 positions (26) of the thymine ring using dimethyl sulfate. The dimethyl 
urea moiety was then substituted with thiourea to replace the carbonyl with a thiol (27). 
Due to the higher nucleophilicity of sulfur compared to nitrogen, the thiol undergoes 
nucleophilic attack of the C-6 position in a Michael addition followed by β-elimination of 
the methylated amine. The thiourea then undergoes nucleophilic attack at the C-4 
position with elimination of N,N’-dimethylurea to form a 1,3-thiazine ring (Figure 2.3.).7 
The 1,3-thiazine undergoes rearrangement to the pyrimidine ring under alkali conditions 
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to form thiothymine.8-10 The thiol group of the thiothymine was then protected with 4-
methoxybenzyl chloride (30) under basic conditions. The nucleobase (31) was then 
alkylated with ethyl bromoacetate using sodium ethoxide to yield the N-1 alkylated 
product (32) as the major product and the O-alkylated product as the minor product.  
 
Figure 2.3. Mechanism of nucleophilic attack of 1,3-dimethyl thymine by thiourea to 
form 1,3-thiazine 
 
2.2.6. Thiouracil and thiothymine PNA monomers 
The aminoethylglycine backbone was synthesized (Scheme 2.7.) with a methyl 
ester protecting group on the C-terminal carboxylic acid and the fmoc protecting group 
on the N-terminal amine. The backbone was previously synthesized as the 
dihydrochloride salt following literature procedures, an excess of ethylenediamine was 
alkylated with 2-chloroacetic acid, then protected using thionyl chloride and methanol 
(34).11, 12 The fmoc group was added to the N-terminus of the methyl aminoethyl glycinate 
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using fmoc-succinimide under basic conditions, then the protected backbone was isolated 
and stored as the hydrochloride salt (35).13   
The alkylacetate of the protected nucleobase (32) was hydrolyzed using a solution 
of aqueous lithium hydroxide, to obtain the carboxylic acid functional group (33) for 
attachment to the aminoethylglycine backbone. The protected nucleobase was then 
reacted with a solution of hexafluorophosphate benzotriazole tetramethyl uroniom 
(HBTU) and diisopropylethyl amine (DIPEA), which acts as the coupling agent by forming 
an active ester on the methylene carbonyl linker of the nucleobase. The activated 
nucleobase is then reacted with the protected aminoethylglycine backbone to form the 
PNA monomer (36). The methyl ester protecting the C-terminus of the PNA monomer is 
then hydrolyzed using a solution an aqueous lithium hydroxide to form the C-terminus 
carboxylic acid (37). The kinetics of the reactivity of the C-terminus protecting group 
compared to the N-terminus protecting group under aqueous alkali conditions favours 
hydrolysis of the methyl ester rather than removal of the fmoc group, giving selective 
deprotection of the PNA backbone.  
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Scheme 2.7. Synthesis of thiouracil and thiothymine PNA monomer (37) 
 
Basic conditions to remove the fmoc protecting group uses a solution of 20 % 
piperidine (pKa = 11), a weaker base than lithium hydroxide (H2O pKa = 16), however 
selectivity for the hydrolysis of the methyl ester is due to faster kinetics of the ester 
hydrolysis using a hydroxide base. Amine bases are effective in the removal of the fmoc 
group since the acidolysis of the fmoc group results in the formation of highly reactive 
dibenzofulvene as a byproduct of the reaction, which is trapped by the amine base to 
form stabile adducts. Amine bases such as piperidine effectively trap the dibenzofulvene 
intermediate which drives the deprotection reaction to completion.14-16 This driving force 
of the reaction is not present using a hydroxide base, which slows the rate of fmoc 
deprotection, and kinetically favours hydrolysis of the methyl ester giving selectivity for 
deprotection of the C-terminus. 
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 Hydrolysis of the C-terminus methyl ester yields the desired thiouracil or 
thiothymine PNA monomer for oligomerization. The monomers where characterized 
using 1H NMR and 13C NMR spectroscopy and high-resolution mass spectrometry (HRMS). 
The 1H NMR spectra shows several rotamer structures resulting from the amide bond 
formed between the methylene carbonyl linker and the aminoethyl glycine backbone and 
resulting from the carbamate resulting from fmoc protection of the N-terminus. The 
rotamers result from resonance of the nitrogen electrons into the π-bonding of the amide 
group. The greater electronegativity of the oxygen pulls greater electron density, causing 
partial π-bonding between the nitrogen and the carbon which prevents free rotation 
around the amide bonds. This results in resonance structures with E and Z conformational 
isomers from the amide bond and results in major and minor 1H NMR signals for many of 
the alkyl protons (Figure 2.4.).  
 
Figure 2.4. Resonance structures from amide and carbamate rotamers of PNA monomer 
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2.3. Conclusions 
 This chapter demonstrates the synthesis of thiouracil and thiothymine 
nucleobases with various benzyl based protecting groups (Figure 2.5.) on the 2-position 
thiol group. The addition of electron donating functional groups at the ortho- and para- 
positions of the benzene ring increases the electron density on the benzylic position. The 
addition of methoxy substituents onto the ortho- and para- positions donates electron 
density to the benzylic position through resonance through the aromatic ring. The next 
chapter will investigate the rate of acidolysis of the protecting group under standard 
fmoc-based SPPS deprotection conditions. This research aims to develop a highly acid 
labile protecting group for the thiol protecting group compared to the para-
methoxybenzyl group used for boc-based pcPNA oligomerization. Furthermore, the 
deprotection rate was compared to the rate of acidolysis of the recently reported 2-
methyl-4-methoxybenzyl protecting group developed for fmoc-based synthesis of pcPNA. 
Finally, using common coupling conditions the protected nucleobase was attached to the 
PNA backbone to synthesize the thiouracil and thiothymine PNA monomer for PNA 
oligomerization.  
 
Figure 2.5. Benzyl based protecting groups on thiouracil  
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Chapter 3: Deprotection and oligomerization of thiouracil and thiothymine monomers 
3.1. Introduction 
 The Hammett principle describes the linear effects of substituents in the meta and 
para positions of a benzene ring on the rate and on the equilibrium of a reaction on a side 
chain attached to the aromatic ring.1, 2 The addition of electron donating groups and 
electron withdrawing groups to the benzene ring affect the electron density at the 
benzylic position. The Hammett principle describes the cumulative effect of electron 
donating and withdrawing groups at the meta- and para- position on the rate or 
equilibrium of reactions at the benzylic position caused by displacement of electron 
density on the aromatic ring. This linear relationship is not maintained with substituents 
at the ortho- position of the benzylic ring due to steric and electronic interactions 
between the ortho- and benzylic substituents. 
 The use of the 4-methoxybenzyl protecting group for the protection of the 
thiouracil nucleobase for boc-based peptide synthesis demonstrated the cleavage of the 
protecting group under treatment with strongly acidic trifluoromethylsulfonic acid. Thus, 
to improve the acid lability of the thiol protecting group, electron donating groups were 
added to the aromatic ring to push electron density to the benzylic position. The greater 
electron density on the benzylic position serves to stabilize the benzylic carbocation 
formed from the cleavage of the benzyl based protecting group. Several protected 
thiouracil nucleobases were synthesized with benzyl based protecting groups to test the 
cleavage of the protecting group under treatment with milder acidic conditions used for 
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fmoc-based oligomerization. The addition of methyl and methoxy groups to the aromatic 
ring were used to increase electron density on the benzylic position and drive the 
acidolysis of the protecting group.  
3.2. Results of benzyl based protection acidolysis  
 The stability of the various methyl and methoxy benzyl protecting groups was 
tested under standard deprotection conditions which uses a solution of 95 % 
trifluoroacetic acid (TFA) and 5 % triethyl silane which quenches the resulting benzylic 
carbocation generated by acidolysis. The deprotection was monitored by 1H NMR and the 
integration of the benzylic protons was used to monitor the progression of the reaction, 
while the integration of the methylene carbonyl protons was used as a reference for the 
integration. A drop of chloroform was added to the TFA solution as a solvent reference 
for the NMR spectra.  
 Initial studies of the deprotection of the 4-methoxybenzyl protected thiouracil 
found that rapid acidolysis of the thioether occurred under standard deprotection 
conditions. The initial recording of the 1H NMR spectra occurred 4 min after the addition 
of the TFA solution to the 4-methoxybenzyl protected thiouracil. The initial spectra 
showed complete deprotection of the thiouracil had occurred prior to the initial 
measurement, suggesting rapid acidolysis of the thioether was occurring. This study 
suggested that the 4-methoxybenzyl protecting group originally developed for boc-based 
oligomerization was easily removed under TFA deprotection conditions. Due to the acid 
lability of the 4-methoxbyenzyl protecting group upon treatment with TFA, the thiouracil 
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protecting group was likely removed during boc-based synthesis of the pcPNA oligomer. 
Since this study showed the 4-methoxybenzyl protecting group is removed under the 
same deprotection conditions as the N-boc protecting group, the thiouracil protection 
was likely cleaved during boc-based oligomerization. This suggests that the thiol 
protecting group is not necessary for the oligomerization, and protection of the thiol 
group is only necessary for blocking S-alkylation and directing alkylation to the N-1 
position.  
 Due to the high lability of the 4-methoxybenzyl group when treated with standard 
deprotection conditions, milder deprotection conditions were used to compare the 
relative rates of acidolysis of the benzyl based protecting groups. The acidolysis of the 
benzyl protecting groups was tested using solutions containing a lower concentration of 
TFA, and the deprotection of the 4-methoxybenzyl group was easily monitored using a 
solution of 2 % TFA and 1% triethylsilane in deuterated chloroform. The acidolysis of the 
protecting group was monitored by 1H NMR; the integration of the benzylic protons and 
the methylene carbonyl protons was measured at 2 min intervals over 2 hours or until 
complete deprotection had occurred (Figure 3.1.). The integration of the methylene 
carbonyl protons was used as a reference for the integration and was recorded as 2 
protons, then the relative integration of the benzylic protons was plotted against the 
reaction time. The half-life of the thioether under acidolysis conditions was used to 
compare the stability of the benzyl based protecting groups (Figure 3.2.).  
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Figure 3.1. 1H NMR spectra of S-(2-methyl-4-methoxybenzyl)thiouracil acidolysis in a 
solution of 2 % TFA and 1 % triethylsilane in CDCl3.  
 
 Under the 2 % TFA deprotection conditions, the S-(4-methoxybenzyl)thiothymine 
and the S-(4-methoxybenzyl)thiouracil deprotected at similar rates, with the deprotection 
of thiothymine slightly slower than the deprotection of thiouracil. The slightly higher 
stability of the S-(4-methoxybenzyl)thiothymine is likely due to the formation of a more 
stable intermediate upon protonation of the nucleobase. The pKa of thymine (9.86) is 
slightly higher than that of uracil (9.36) which is likely due to the C-5 methyl group, which 
can donate electron density into the pyrimidine ring making thymine a slightly more basic 
nucleobase than uracil.3 Similarly, upon treatment with TFA, the electron donation from 
the methyl group helps to stabilize the positive charge resulting from protonation of the 
nucleobase. The higher stability of the protonated thiothymine compared to the 
thiouracil nucleobase results in a slightly slower acidolysis of the thioether. In the case of 
both the S-(4-methoxybenzyl)thiouracil and S-(4-methoxybenzyl)thiothymine, the 
* 
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majority of the nucleobase was deprotected after 2 hours when treated with mild 
deprotection conditions. This contradicts previous assumptions that strongly acidic 
conditions were necessary for the acidolysis of the protecting group, and as a result a 
more acid labile thiol protecting group was necessary for adapting the thiouracil PNA 
monomer for a standard fmoc-based oligomerization strategy.4, 5 However, this 
assumption was never tested and the conditions necessary for acidolysis were not 
previously examined. Acidolysis of the S-(2-methyl-4-methoxybenzyl)thiouracil was faster 
than the acidolysis of the S-(4-methoxybenzy)thiouracil. The reaction went to completion 
within 90 min, and the protected nucleobase had a half-life of around 13 min when 
treated with the solution of 2 % TFA (Figure 3.2.). The 2,4-dimethoxybenzyl was the most 
acid labile of the protecting groups studied, with complete deprotection of the S-(2,4-
dimethoxybenzyl)thiouracil occurring within 4 min of treatment with a solution of 2 % 
TFA. Since the first 1H NMR measurement was recorded after 4 min of treatment with 
TFA, no measurements of the acidolysis were recorded and the half-life of the reaction 
could not be determined. The short reaction time for the acidolysis of the 2,4-
dimethoxybenzyl protecting group demonstrates the highly acid labile nature of the 
newly developed thiouracil protecting group, however kinetic studies of the existing 4-
methoxybenzyl protecting group suggest that protection of the thiouracil nucleobase is 
not necessary during PNA oligomerization. 
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Figure 3.2. Relative 1H integration of benzylic protons of S-(2-methyl-4-
methoxybenzyl)thiouracil,  S-(4-methoxybenzyl)thiouracil, and  S-(4-
methoxybenzyl)thiothymine, over time. 
 
 The change in the benzylic integration over time was plotted to fit a first order 
reaction curve with the natural logarithm of the benzylic proton integration against the 
reaction time. The linear trend of the graph suggests the kinetics of the acidolysis reaction 
as a first order reaction, dependent on the rate of decomposition of the protonated 
nucleobase. Upon treatment of the nucleobase with the TFA solution, the acid-base 
reaction occurs quickly resulting in the protonation of the nucleobase. Protonation of the 
nucleobase occurs rabidly, with the rate limiting step being the decomposition of the 
protonated nucleobase resulting in the cleavage of the thioether. From the first order 
reaction plots, the half-life of the reaction is calculated to compare the relative rate of 
acidolysis of the benzyl based protecting groups.  
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 20 40 60 80 100 120
1 H
 I
n
te
gr
at
io
n
Time (min)
46 
  
 A first order reaction proceeds dependent linearly on the concentration of a single 
reactant (Eq. 1), so the equation for the rate is expressed as: 
𝑟𝑎𝑡𝑒 =  −
𝑑[𝐴]
𝑑𝑡
= 𝑘[𝐴] 
(1) 
Where the rate of the reaction is the change in concentration of the reactants over time, 
which for a first order, unimolecular reaction is dependent on the concentration of a 
single reactant ([𝐴]), and a rate constant (𝑘). The integration of the first order rate 
equation (Eq. 1) yields a linear equation (Eq. 4) with respect to the natural logarithm of 
the concentration of the reactant. 
∫
𝑑[𝐴]
[𝐴]
[𝐴]
[𝐴]𝑜
=  ∫ −𝑘𝑑𝑡
𝑡
𝑡𝑜
 
(2) 
ln[𝐴] − ln[𝐴]𝑜 = −𝑘𝑡 
(3) 
ln[𝐴] = ln[𝐴]𝑜 − 𝑘𝑡 
(4) 
The integration of the benzylic protons is used as the concentration of the reactant and 
the natural logarithm of the integration plotted with time yields a linear first order rate, 
with the slope of the plot as the rate constant (Figure 3.3.). Using the rate constant, the 
half-life of the acidolysis of the benzyl based protecting groups is calculated to compare 
the relative stability of the protecting groups to deprotecting conditions.  
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Figure 3.3. First order reaction curves for a) S-(4-methoxybenzyl)thiouracil, b) S-(4-
methoxybenzyl)thiothymine, and c) S-(2-methyl-4-methoxybenzyl)thiouracil treated with TFA 
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Solving equation 4 for the half-life of the reaction, the time is calculated for half the initial 
concentration (Eq. 6, Table 3.1). 
1
2
= 𝑒
−𝑘𝑡1
2
 
 
(5) 
𝑡1
2
= −
ln 2
𝑘
 
(6) 
Table 3.1. Half-life of acidolysis of benzyl based protecting groups of thiouracil and 
thiothymine nucleobases 
Protecting group Nucleobase Rate constant (k) Half-life (𝒕𝟏/𝟐) 
(min) 
4-methoxybenzyl SU 0.0111 62 
4-methoxybenzyl ST 0.0070 99 
2-methyl-4-methoxybenzyl SU 0.0527 13 
2,4-dimethoxybenzyl SU - <1 
 
 The acidolysis of the benzyl based protecting groups of thiouracil and thiothymine 
demonstrated the highly acid-labile nature of the newly synthesized 2,4-dimethoxybenzyl 
protected thiouracil nucleobase. This protecting group was rapidly removed under 
treatment with mild TFA conditions, demonstrating a high sensitivity to deprotecting 
conditions. Furthermore, this study demonstrated the previously unstudied acid-lability 
of the 2-methyl-4-methoxybenzyl and 4-methoxybenzyl protecting previously developed 
for the synthesis of thiouracil PNA monomers. The unexpected acidolysis of the 4-
methoxybenzyl protecting group suggests the protecting group is removed under 
standard boc-based oligomerization conditions, thus the thiol protection is likely 
unnecessary for oligomerization. To test this hypothesis, oligomerization was performed 
using an unprotected thiouracil PNA monomer and compared to previous oligomerization 
conditions.  
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3.3. Synthesis of pcPNA oligomers 
 The pcPNA oligomers were synthesized using standard fmoc-based solid phase 
peptide synthesis conditions. A series of 10-mer PNA oligomers were synthesized with the 
sequence NH2-Lys-GXAGAXCACX-Lys-OH, where either the unmodified thymine PNA 
monomer, or the novel thiouracil or thiothymine PNA monomers were used in the 
synthesis of the 10-mer sequences. The PNA oligomers were synthesized on a polystyrene 
resin with a Rink amide linker (Figure 3.4). The polystyrene resin provides an insoluble 
support on which the PNA is oligomerizes which allows easy synthesis. The solid support 
allows the oligomer to be isolated by filtration and excess reagent is easily washed with 
dimethylformamide and dichloromethane. Washing the solid support with 
dichloromethane swells the resin, while washing with dimethylformamide contracts the 
resin. Alternating washes of dimethylformamide and dichloromethane results in a 
swelling and contracting of the resin which washes excess reagents through the 
polystyrene resin. The polystyrene resin is functionalized with Rink amide linkers to which 
the C-terminus of the peptide is attached. The Rink amide linker was developed as a more 
acid labile linker, compared to the Merrifield linker (Figure 3.4), which allows the oligomer 
to be removed from the polystyrene resin under treatment with milder acidic conditions. 
Linkers originally developed for boc-based peptide synthesis required stronger acidic 
conditions to remove the oligomer, as the linkage had to be resistant to treatment with 
TFA used for boc deprotection.  
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Figure 3.4. Merrifield linker and Rink amide linker 
 
 Prior to automated oligomerization the polystyrene resin is preloaded with Nα-
fmoc-Nε-boc-Lysine residue using HBTU and DIPEA as coupling agents to couple the C-
terminus of the lysine to the Rink amide linker. Uncoupled linkers are capped using acetic 
anhydride to prevent additional coupling to the linker during oligomerization. Automated 
oligomerization is then carried out on the preloaded resin (K-PS) from the C-terminus to 
the N-terminus of the peptide using commercially available fmoc/bhoc protected PNA 
monomer and newly synthesized SU or ST PNA monomers. The FastMoc oligomerization 
procedure first uses a solution of 20 % 4-methylpiperidine to remove the N-terminal fmoc 
protecting group. The deprotection removal of the fmoc group results in the formation of 
dibenzofulvene piperidine adduct and piperidine-carbamate salt (Figure 3.5.), which are 
washed away with excess reagent. The deprotection of the terminal amine is monitored 
by conductivity monitoring, which detects conductivity resulting from the presence of the 
carbamate salt during deprotection. The prepared PNA monomers are mixed with a 
solution of HBTU and DIPEA to form an active ester on the C-terminus of the monomer. 
The activated PNA monomer is then mixed with the resin bound oligomer with the 
unprotected N-terminus to grow the oligomer strand. The N-terminus of the unreacted 
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oligomers are capped using acetic anhydride to prevent the synthesis of oligomers with a 
nucleotide deletion. Capping with the acetic anhydride truncates the oligomerization of 
the PNA strand. The deprotection, oligomerization and capping are repeated with each 
PNA monomer to synthesize the PNA strand. The PNA oligomer is cleaved from the 
polystyrene resin and removal of the bhoc and benzyl based protecting group from the 
nucleobases using a solution of 95 % TFA. The PNA oligomers were purified by high-
pressure liquid chromatography (HPLC), and the purified oligomers were characterized by 
high-resolution mass spectrometry (Table 3.2). 
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Figure 3.5. Byproducts of the cleavage of fmoc protecting group from N-terminus 
 To test the need for a protecting group on the thiouracil nucleobase during 
oligomerization, a sample of the prepared thiouracil PNA monomer (SU(MMOB)) was 
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deprotected prior to oligomerization. The SU(MMOB) monomer was treated with the 95 
% TFA solution for deprotection of the thiouracil nucleobase to yield the fmoc-SU-AEG-
OH PNA monomer for oligomerization. The thiouracil monomer without a protecting 
group on the nucleobase was then used for oligomerization under standard fmoc-based 
oligomerization conditions. The synthesized oligomer was purified by HPLC. The success 
of the oligomerization without a nucleobase protecting group was qualitatively analyzed 
by comparing the chromatogram of the unpurified oligomer to the chromatogram of the 
pcPNA oligomer synthesized using the SU(MMOB) monomer.  
Table 3.2. Observed high-resolution mass of synthesized PNA oligomers 
a Oligomer calculated and observed as the dicationic [M+2Na]2+  
 
 The mass spectra of the synthesized PNA oligomers closely correlates with the 
calculated mass for the PNA oligomer. Additionally, mass signals were detected 
corresponding to the calculated [M+2Na]2+ and [M+3Na]3+ masses for all oligomers. The 
close correlation with the calculated masses suggests the complete synthesis of the PNA 
oligomers. This indicates the successful incorporation of the novel PNA monomers into 
the oligomer using standard fmoc-based oligomerization procedures. Additionally, using 
the thiouracil monomer with no protecting group on the thiol resulted in the successful 
PNA Protecting 
group 
PNA sequence Molecular 
formula 
Calculated 
[M+Na]+ 
Observed 
[M+Na]+ 
PNA-T 
 
None KGTAGATCACTK C120H159N61O33 3005.2536 3005.2551 
PNA-SU 4-
methoxybenzyl 
KGSUAGASUCACSUK C117H153N61O30S3 3011.1382 3011.2430 
PNA-SU 
 
None KGSUAGASUCACSUK C117H153N61O30S3 3011.1382 3011.2624 
PNA-ST 4-
methoxybenzyl 
KGSTAGASTCACSTK C120H159N61O30S3 1538.0874a 1538.0963a 
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synthesis of the desired PNA oligomer. The mass of the oligomer synthesized without 
nucleobase protecting group matched that of the oligomer synthesized with the 
protected thiouracil nucleobase, while the HPLC chromatogram showed no significant 
impurities resulting from truncated oligomers during oligomerization. The 
oligomerization demonstrated that the protecting group on the thiol of the nucleobase 
was unnecessary for oligomerization.  
3.4 Conclusions and future work 
 Studies of the deprotection rates of benzyl based protecting groups on the 
thiouracil nucleobase demonstrated the successful synthesis of a highly acid labile 
protecting group for fmoc-based synthesis of pcPNA oligomers. The addition of electron 
donating groups to the benzyl group stabilizes the benzylic carbocation resulting from the 
acidolysis of the thioether. Stabilizing the carbocation intermediate allows cleavage of the 
protecting group under milder acidic conditions. In addition to confirming the cleavage of 
the novel thiouracil protecting group under standard deprotection conditions, the study 
of the acidolysis discovered the cleavage of the previously synthesized 4-methoxybenzyl 
protecting group, used for boc-based oligomerization, under standard boc deprotection 
conditions. This suggested that a protecting group on the thiol was not necessary for PNA 
oligomerization.  
 The novel thiouracil and thiothymine PNA monomers were incorporated into PNA 
oligomers using standard fmoc-based oligomerization procedures. Characterization of the 
oligomers by mass spectrometry demonstrates the successful incorporation of the novel 
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thiouracil and thiothymine monomers into the PNA oligomer using standard fmoc-based 
oligomerization. Furthermore, the PNA oligomers were synthesized using thiouracil 
monomers without nucleobase protection, demonstrating the thiol protecting group is 
only necessary for directing alkylation to the N-1 position and is not necessary for 
oligomerization. 
 Future work will aim to test the stability of the synthesized PNA oligomer 
hybridization with complementary PNA and DNA oligomers. Hybridizing the PNA 
oligomers with a complementary target oligomer, then heating the duplex to determine 
the melting temperature of the duplex can be used to determine the stability of the PNA-
PNA and PNA-DNA duplexes. Comparing the melting temperature of the thiouracil PNA 
monomer with the thiothymine PNA monomer can be used to determine the effect of 
replacing the thiouracil nucleobase with the thiothymine nucleobase on the stability of 
the PNA hybridization. Further future work will aim to develop a more effective synthesis 
of the fmoc-SU-AEG-OH monomer. The synthesis of the PNA oligomer using the 
unprotected thiouracil nucleobase demonstrated the thiol group does not need 
protecting during oligomerization. Therefore, a more effective monomer synthesis could 
use a fmoc-AEG-Otbutyl backbone rather than the fmoc-AEG-Omethyl backbone. The 
tbutyl ester protection of the C-terminus is removed under acidic conditions, rather than 
the basic conditions necessary for removal of the methyl ester protecting group. This is 
orthogonal to the fmoc deprotection conditions and would prevent unwanted 
deprotection of the N-terminus during ester hydrolysis. The acidic conditions would 
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remove the protecting group from both the nucleobase and the C-terminus, yielding the 
PNA monomer for oligomerization.  
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Chapter 4: Experimental Procedures 
 
Scheme 4.1. Attempted synthesis of methyl 2-((2-((2,4,6-
trimethoxybenzyl)thio)pyrimidin-4-yl)oxy)acetate 
 
2,4,6-Trimethoxybenzyl alcohol (8) 
 
  To a solution of 2,4,6-trimethoxybenzaldehyde (1.00 g, 5.10 mmol) and 0.5 M 
sodium hydroxide in methanol (30 mL) was added sodium borohydride (290 mg, 7.65 
mmol) portionwise. The resultant solution was stirred for 2 h, then the reaction was 
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quenched with 30 mL water. The solution was concentrated under reduced pressure to 
approximately 30 mL, then the product was extracted into ether (3 x 20 mL). The organic 
layers were combined, washed with brine, dried over sodium sulfate, then the solvent 
evaporated to yield a clear, colourless oil which crystallized overnight (830 mg, 4.19 
mmol, 82%). 1H NMR (400 MHz, CDCl3) δ 6.12 (s, 2H), 4.71 (s, 1H), 4.69 (s, 1H), 3.82 (s, 
6H), 3.81 (s, 3H). This conformed closely with the 1H NMR spectrum previously reported 
in the literature.1  
2-(2,4,6-Trimethoxy-3-chlorobenzyl)thiouracil (10) 
 
To a solution of 8 (2.00 g, 10.1 mmol) and triphenyl phosphine (1.94 g, 15.1 mmol) 
in 100 mL dichloromethane at 0 oC, was added N-chlorosuccinimide (1.62mg, 12.1 mmol). 
The solution was stirred for 1 h., then added to a suspension of 2-thiouracil (1.29 g, 10.1 
mmol) and sodium carbonate (2.79 g, 20.2 mmol) in 100 mL dimethylformamide. The 
mixture was stirred for 90 min., then neutralized with 40 mL saturated citric acid. The 
solution was diluted with 150 mL water, then extracted in ethyl acetate (3 x 150 mL). The 
organic layers were combined, washed with water (4 x 150 mL), and brine (150 mL), dried 
over sodium sulfate, then the solvent was evaporated under reduced pressure to yielded 
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crude compound 10 combined with triphenylphosphine oxide as an off white solid (2.55 
g). The crude product was used for further synthesis.   
Methyl 2-((2-((2,4,6-trimethoxy-3-chlorobenzyl)thio)pyrimidin-4-yl)oxy)acetate (11) 
 
 To a solution of crude 10 (2.55 g) and sodium carbonate (2.03 g, 11.1 mmol) in 120 
mL dimethylformamide at 0 oC was added methyl bromoacetate (1.05 mL, 11.1 mmol), 
then the reaction was stirred at 0 oC for 15 min, then allowed to warmed to room 
temperature. The reaction was stirred for 4 h, then diluted with water (200 mL) and 
extracted with ethyl acetate (3 x 120 mL). The organic layers were combined, washed with 
water (4 x 100 mL) and brine (100 mL), dried with sodium sulfate, filtered, then the solvent 
was evaporated under reduced pressure, yielding a crude orange oil (3.84 g). The crude 
product was purified by column chromatography on silica gel (1:9 to 1:1 ethyl acetate: 
hexanes) to yield the pure product as light-yellow crystals (234 mg, 0.56 mmol, 5.6 % from 
(8)). 1H NMR (400 MHz, CDCl3) δ 8.24 (d, J = 5.7 Hz, 1H), 6.48 (d, J = 5.7 Hz, 1H), 6.27 (s, 
1H), 4.89 (s, 2H), 4.37 (s, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 3.79 (s, 3H), 3.71 (s, 3H). 13C NMR 
(400 MHz, CDCl3) δ 172.2, 168.7, 167.5, 157.9, 157.7, 156.3, 156.0, 111.5, 108.6, 103.4, 
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92.6, 62.5, 61.8, 56.4, 56.1, 52.3, 24.7. LRMS (EI) calculated for C17H19ClN2O6S [M]+ 414.07, 
found 414.09. 
 
Scheme 4.2. Synthesis of methyl 2-(2-((2,4-dimethoxybenzyl)thio)-4-oxopyrimidin-1(4H)-
yl)acetate (16a) 
 
2,4-Dimethoxybenzyl alcohol (13) 
 
To a solution of 2,4-dimethoxybenzaldehyde (5.00 g, 30.09 mmol) and 0.5 M 
sodium hydroxide in 200 mL methanol was added sodium borohydride (1.37 g, 36.11 
mmol) portionwise. The solution was stirred for 1 h, then the reaction was quenched with 
water. The solution was concentrated under reduced pressure, then the product was 
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extracted into ether. The organic layers were combined, washed with brine, dried over 
sodium sulfate, filtered, then the solvent was evaporated under reduced pressure to yield 
13 as a clear, colourless oil which crystalized overnight (4.45 g, 26.46 mmol, 88 %). 1H 
NMR (400 MHz, CDCl3) δ 7.18 (d, J = 8.0 Hz, 1H), 6.52-6.42 (m, 2H), 4.63 (s, 2H), 3.86 (s, 
3H), 3.82 (s, 3H), 2.27 (s, 1H). 13C NMR (400 MHz, CDCl3) δ 160.7, 158.6, 129.7, 121.8, 
103.9, 98.6, 61.7, 55.4, 55.3. 
2-(2,4-Dimethoxybenzyl)thiouracil (15) 
 
A solution of 2,4-dimethoxybenzyl alcohol (13) (4.12 g, 24.5 mmol) and pyridine 
(3.95 mL, 49.0 mmol) in 50 mL dry ether was cooled to 0 oC, then thionyl chloride (4.89 
mL, 67.4 mmol) was added dropwise to solution over 15 min. The solution was stirred for 
90 min at 0 oC, then quenched with 50 mL ice cold water. The ethereal layer was collected, 
and the aqueous layer was extracted with ether (3 x 25 mL). The organic layers were 
combined, washed with water (50 mL), and 5:1 saturated sodium chloride: saturated 
sodium bicarbonate (3 x 60 mL), and then dried over sodium sulfate. Dimethylformamide 
(10 mL) was added to solution, then the ether was evaporated under reduced pressure. 
The resulting dimethylformamide solution was added dropwise to a solution of 2-
thiouracil (1) (1.57 g, 12.26 mmol) and triethylamine (2.05 mL, 14.71 mmol) in 50 mL 
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dimethylformamide at 0 oC. The resultant solution was stirred for 4 h at 0 oC, then diluted 
with water and extracted with dichloromethane (3 x 40 mL). The dichloromethane layers 
were combined, washed with water (4 x 50 mL), and brine (50 mL), dried over sodium 
sulfate then the solvent was evaporated under reduced pressure. The resulting white 
power was triturated with cold ether, yielding 14 as a pure white solid (2.41 g, 8.66, 71 
%). 1H NMR (400 MHz, CDCl3) δ 7.89 (d, J = 6.6 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 6.49-6.40 
(m, 2H), 6.20 (d, J = 6.6 Hz, 1H), 4.42 (s, 2H), 3.86 (s, 3H), 3.81 (s, 3H). 13C NMR (400 MHz, 
CDCl3) δ 164.4, 162.6, 160.9, 158.4, 154.8, 131.4, 116.6, 110.8, 104.3, 98.5, 55.5, 55.4, 
29.7. HRMS (EI) calculated for C13H14N2O3S [M]+ 278.0725, found 278.0720. 
Methyl 2-((2-((2,4-dimethoxybenzyl)thio)pyrimidin-4-yl)oxy)acetate (16b) 
 
 To a solution of 14 (1.00 g, 3.59 mmol) and sodium carbonate (1.24 g, 8.98 mmol) 
in 60 mL dimethylformamide was added methyl bromoacetate (0.52 mL, 5.39 mmol) then 
the solution was heated to 80 oC. The reaction was stirred for 2 h at 80 oC, then diluted 
with water (70 mL) and extracted with dichloromethane (4 x 50 mL). The dichloromethane 
layers were combined, washed with water (4 x 60 mL) and brine (60 mL), dried over 
sodium sulfate, filtered, then the solvent was evaporated under reduced pressure, 
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yielding a yellow solid (1.23 g, 3.37 mmol, 94%). 1H NMR (400 MHz, CDCl3) δ 8.31 (d, J = 
5.7 Hz, 1H), 7.31 (d, J = 8.2 Hz, 1H), 6.55 (d, J = 5.7 Hz, 1H), 6.50-6.40 (m, 2H), 4.93 (s, 2H), 
4.34 (s, 2H), 3.86 (s, 3H), 3.81 (s, 3H), 3.78 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 172.0, 
168.6, 167.5, 160.4, 158.6, 157.8, 130.8, 117.6, 104.1, 103.5, 98.6, 62.4, 55.5, 55.4, 52.2, 
29.7. 
Methyl 2-(2-((2,4-dimethoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (16a) 
 
To a solution of sodium (165 mg, 7.18 mmol) in 15 mL methanol was added 7 (1.00 
g, 3.59 mmol), then the solution was stirred and heated to reflux. Methyl bromoacetate 
(0.79 mL, 7.18 mmol) was added to the reaction, the solution was stirred for 2 h at reflux, 
then cooled to room temperature and the solvent was evaporated under reduced 
pressure. The resulting residue was dissolved in 25 mL water then extracted with a 
solution of 3:1 dichloromethane: methanol (2 x 80 mL). The organic layers were 
combined, dried over sodium sulfate, filtered, then the solvent was evaporated under 
reduced pressure to yield a white residue. The residue was purified by column 
chromatography on silica gel (for 15, 1% methanol in dichloromethane; for 16a, 5% 
methanol in dichloromethane to 10% methanol in dichloromethane), yielding 16a as a 
pure white solid (289 mg, 0.79 mmol, 22 %). 1H NMR (400 MHz, CDCl3) δ 7.34 (d, J = 8.9 
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Hz, 1H), 7.07 (d, J = 7.6 Hz, 1H), 6.41-6.34 (m, 2H), 6.02 (d, J = 7.6 Hz, 1H), 4.47 (s, 2H), 
4.44 (s, 2H), 3.77 (s, 3H), 3.74 (s, 3H), 3.73 (s, 3H). 13C NMR (400 MHz, CDCl3) δ 167.8, 
166.4, 163.8, 160.9, 158.6, 143.6, 131.8, 115.9, 110.0, 104.1, 98.5, 55.3, 53.1, 52.6, 41.9, 
31.3. HRMS (EI) calculated for C16H18N2O5S [M]+ 350.0936, found 350.0949. 
 
Scheme 4.3. Synthesis of ethyl 2-(2-((2-methyl-4-methoxybenzyl)thio)-4-oxopyrimidin-
1(4H)-yl)acetate (21) 
 
2-Methyl-4-methoxybenzyl alcohol (18) 
 
 To a solution of 2-methyl-4-methoxybenzaldehyde (2.03 g, 12.8 mmol) in 32 mL 
ethanol was added sodium borohydride (519 mg, 13.7 mmol). The resultant solution was 
stirred for 15 min., then the reaction was quenched by the addition of 240 mL water. The 
solution was acidified with 4 M hydrochloric acid, then the product was extracted in 
diethyl ether (3 x 80 mL). The ethereal layers were combined, washed with water (60 mL), 
and brine (60 mL), then dried over sodium sulfate. The solvent was evaporated under 
reduced pressure to yield the pure product as a clear, colourless oil (2.00 g, 12.8 mmol). 
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1H NMR (400 MHz, CDCl3) δ 7.19 (d, 1H, J = 8.3 Hz), 6.71 (d, 1H, J = 2.7 Hz), 6.68 (dd, 1H, J 
= 2.7, 8.3 Hz), 4.59 (s, 2H), 3.76 (s, 3H), 2.33 (s, 3H), 1.59 (s, 1H). This closely corresponded 
to the 1H NMR spectrum previously reported in the literature.2 
2-(2-Methyl-4-methoxybenzyl)thiouracil (20) 
 
 To a solution of 2-methyl-4-methoxybenzyl alcohol (2.00 g, 12.8 mmol) in 80 mL 
dry dichloromethane at 0 oC was added thionyl chloride (1.05 mL, 14.4 mmol) dropwise, 
then the solution was stirred for 2 h at 0 oC. The reaction was added to a solution of ice 
cold saturated sodium bicarbonate (250 mL), the dichloromethane layer was separated, 
then the aqueous layer was extracted with diethyl ether (2 x 60 mL). The organic layers 
were combined, washed with water (80 mL), and brine (80 mL), then dried over sodium 
sulfate. The solvent was evaporated under reduced pressure to yield a clear colourless 
oil. The resulting oil was dissolved 8 mL ethanol then added to a solution of 2-thouracil 
(833 mg, 6.58 mmol) in 8 mL ethanol and 8 mL aqueous potassium hydroxide (474 mg, 
4.45 mmol KOH in H2O). The resultant reaction was stirred overnight at room 
temperature, then the solvent was evaporated under reduced pressure. A solution of 
saturated sodium bicarbonate (20 mL) was added to the resultant residue then the 
precipitate was collected by filtration, washed with water, ethanol, ethyl acetate, and 
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diethyl ether to yield the product as pure white crystals (1.49 g, 5.60 mmol, 86 %). 1H 
NMR (400 MHz, DMSO-d6) δ 7.29 (d, 1H, J = 8.3 Hz), 6.79 (d, 1H, J = 2.1 Hz), 6.72 (dd, 1H, 
J = 2.1 Hz, 8.3 Hz), 4.35 (s, 2H), 3.72 (s, 3H), 2.32 (s, 3H). This closely corresponded to the 
1H NMR spectrum previously reported in the literature.2 
Ethyl 2-(2-((2-methyl-4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (21) 
 
 To a solution of sodium (273 mg, 11.4 mmol) dissolved in ethanol (13 mL) was 
added 2-(2-methyl-4-methoxybenzyl)thiouracil (1.49 g, 5.60 mmol). The resultant 
suspension was stirred and heated to reflux until the solids dissolved, then ethyl 
bromoacetate (1.26 mL, 11.4 mmol) was added dropwise, then the solution was stirred 
at reflux for 2 h. The mixture was cooled to room temperature, then the ethanol was 
evaporated under reduced pressure. Water (15 mL) was added to the resulting residue, 
and the product was extracted in a solution of 3:1 dichloromethane: methanol (2 x 60 
mL). The organic layers were combined, dried over sodium sulfate, then evaporated 
under reduced pressure. The resultant residue was purified by column chromatography 
on silica gel (ethyl acetate to 9:1 ethyl acetate: methanol) to yield the product as a pure 
white solid (781 mg, 2.2 mmol, 40 %). 1H NMR (400 MHz, CDCl3) δ 7.25 (d, 1H, J = 8.2 Hz), 
7.08 (d, 1H, J = 7.6 Hz), 6.69 (d, 1H, J = 2.6 Hz), 6.66 (dd, 1H, J = 2.6, 8.2 Hz), 6.08 (d, 1H, J 
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= 7.6 Hz), 4.45 (s, 2H), 4.44 (s, 2H), 4.20 (q, 2H, J = 7.1 Hz), 3.74 (s, 3H), 2.30 (s, 3H), 1.23 
(t, 3H, J = 7.1 Hz). This corresponded closely to the 1H NMR spectrum previously reported 
in the literature.2 
 
Scheme 4.4. Synthesis of ethyl 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-
yl)acetate (3) 
 
4-Methoxybenzyl alcohol (23) 
 
 To a solution of 4-methoxybenzaldehyde (7.00 g, 51.4 mmol) in 60 mL ethanol was 
added sodium borohydride (2.92 g, 77.1 mmol). The resultant solution was stirred for 30 
min, then the reaction was quenched by the addition of 250 mL water. The solution was 
acidified with 4 M hydrochloric acid, then the product was extracted into diethyl ether (3 
x 100 mL). The ethereal layers were combined, washed with water (80 mL), and brine (80 
mL), then dried over sodium sulfate. The solvent was evaporated under reduced pressure 
to yield the pure product as a clear, colourless oil (6.93 g, 50.1 mmol, 97 %). 1H NMR (400 
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MHz, CDCl3) δ 7.27 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.58 (s, 2H), 3.77 (s, 3H), 
1.61 (br s, 1H). This closely corresponded to the 1H NMR spectrum previously reported in 
the literature.3 
2-(4-Methoxybenzyl)thiouracil (2) 
 
To a solution of 4-methoxybenzyl alcohol (6.93 g, 50.1 mmol) in 150 mL dry 
dichloromethane at 0 oC was added thionyl chloride (4.11 mL, 56.4 mmol) dropwise, then 
the solution stirred at 0 oC. After 2 h., the reaction was added to a solution of ice cold 
saturated sodium bicarbonate (300 mL), the dichloromethane layer was separated and 
the aqueous layer was extracted with diethyl ether (2 x 100 mL). The organic layers were 
combined, washed with water (120 mL), and brine (120 mL), then dried over sodium 
sulfate. The solvent was evaporated under reduced pressure to yield a clear colourless 
oil. The resultant oil was dissolved in 15 mL ethanol and then added to a solution of 2-
thouracil (5.77 g, 45.8 mmol) in 15 mL ethanol and 15 mL aqueous potassium hydroxide 
(3.34 g, 56.5 mmol KOH in H2O). The resultant reaction was stirred overnight at room 
temperature, then the solvent was evaporated under reduced pressure. A solution of 
saturated sodium bicarbonate (50 mL) was added to the resultant residue, then the 
precipitate was collected by filtration, washed with water, ethanol, ethyl acetate, and 
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diethyl ether to yield the product as pure white crystals (5.61 g, 22.6 mmol, 50 %). 1H 
NMR (400 MHz, DMSO-d6) δ 11.69 (br s, 1H), 7.88 (d, J = 6.6 Hz, 1H), 7.32 (d, J = 8.7 Hz, 
2H), 6.86 (d, J = 8.7 Hz, 2H), 6.22 (d, J = 6.6 Hz, 1H), 4.42 (s, 2H), 3.81 (s, 3H). This 
corresponded closely with the 1H NMR spectrum previously reported in the literature.3 
Ethyl 2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetate (3) 
 
 To a solution of refluxing ethanol 80 mL was dissolved sodium (370 mg, 16.1 
mmol), then S-(4-methoxybenzyl)thiouracil (2) (3.34 g, 13.4 mmol) was added to the 
solution. Once the 2-(4-methoxybenzyl)thiouracil dissolved, ethyl bromoacetate (1.78 
mL, 16.1 mmol) was added dropwise to the solution, and reaction was stirred at reflux for 
90 min. The reaction was evaporated to dryness, then water was added to the residue 
(100 mL). The aqueous solution was extracted with a solution of 3:1 dichloromethane: 
methanol (2 x 200 mL). The organic layers were combined, dried over sodium sulfate, 
filtered, then evaporated to dryness under reduced pressure. The resultant residue was 
taken up into a solution of 1:1 ethyl acetate: hexanes, the solvent was evaporated under 
reduced pressure, and the resulting residue was triturated with ice cold ethyl acetate to 
yield the pure product as a white solid (712 mg, 2.12 mmol, 16 %). 1H NMR (400 MHz, 
CDCl3) δ 7.34 (d, J = 8.6 Hz, 2H), 7.11 (d, J = 7.6 Hz, 1H), 6.87 (d, J = 8.6 Hz, 2H), 6.13 (d, J 
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= 7.6 Hz, 1H), 4.504 (s, 2H), 4.499 (s, 2H), 4.28 (q, J = 7.2 Hz, 2H), 3.81 (s, 3H), 1.29 (t, J = 
7.2 Hz, 3H). This closely corresponded with the 1H NMR spectra previously reported in the 
literature.3 
Thioester acidolysis 
 To a solution of 0.02 mL trifluoroacetic acid, 0.02 mL triethylsilane and 0.96 mL 
deuterated chloroform was added to 3 mg of protected thiouracil or thiothymine (3, 16a, 
21, 32) and the reaction was monitored by 1H NMR at 2 min. intervals until the reaction 
was completed. The reaction was carried out at 25 OC and monitored for 2 h, or until 
reaction had gone to completion. Integration of benzylic protons was monitored to 
determine the rate of deprotection.  
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Scheme 4.5. Synthesis of 2-(2-((4-methoxybenzyl)thio)-5-methyl-4-oxo-3,4-
dihydropyrimidin-1(2H)-yl)acetic acid (33) 
 
1,3-Dimethylthymine (26) 
 
 To a solution of sodium hydroxide (9.5 g, 237.9 mmol) and thymine (5.00 g, 39.6 
mmol) in a solution of 20 mL water was added dimethyl sulfate (18.8 mL, 198.2 mmol) 
dropwise over 30 min. The solution was stirred for 2 h. until the starting material was 
consumed. The solution was extracted with dichloromethane (3 x 150 mL), the organic 
layers were combined, dried over sodium sulfate, filtered, then the solvent evaporated 
under reduced pressure to yield a white solid (5.1 g, 33.1 mmol, 84 %).  1H NMR (400 MHz, 
DMSO-d6) δ 7.58 (s, 1 H), 3.33 (s, 3 H), 3.27 (s, 3 H), 1.80 (s, 3 H). This closely corresponded 
to the 1H NMR spectrum previously reported in the literature.4 
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Thiothymine (27) 
 
 To a solution of sodium (2.7 g, 115.8 mmol) in 80 mL ethanol was added 1,3-
dimethylthymine (5.1 g, 33.1 mmol) and thiourea (10.1 g, 132.3 mmol). The solution was 
stirred at reflux for 48 h., then the solvent was evaporated under reduced pressure. The 
resultant residue was dissolved in 30 mL water and acidified with concentrated 
hydrochloric acid. The precipitated was collected by filtration, yielding a pure white solid 
(1.6 g, 11.3 mmol, 34 %). 1H NMR (400 MHz, DMSO-d6) δ 12.39 (s, 1H), 12.13 (s, 1H), 7.32 
(s, 1H), 1.78 (s, 3H). 13C NMR (400, DMSO-d6) δ 175.1, 162.4, 138.5, 114.3, 12.4. This 
closely corresponded to the 1H NMR spectrum previously reported in the literature.5 
2-(4-Methoxybenzyl)thiothymine (31) 
 
 To a solution of 25 mL ethanol was added thiothymine (1.00 g, 7.00 mmol) 
followed by aqueous potassium hydroxide (510 mg, 9.10 mmol) in 15 mL water. The 
solution was heated to 45 oC then 4-methoxybenzyl chloride (1.42 mL, 10.5 mmol) was 
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added to the reaction. The reaction was stirred for 8 h., then evaporated to dryness under 
reduced pressure. The resultant residue was suspended in a solution of 10 % sodium 
bicarbonate (20 mL), then the precipitate was collected by filtration, and washed with 
water, methanol, and diethyl ether to yield a pure white solid (1.3 g, 4.96 mmol, 71 %). 
1H NMR (400 MHz, DMSO-d6) δ 12.66 (br, 1H), 7.76 (s, 1H), 7.32 (d, J = 8.6 Hz, 2H), 6.87 
(d, J = 8.6 Hz, 2H), 4.32 (s, 2H), 3.73 (s, 3H), 1.87 (s, 3H). HRMS (EI) calculated for 
C13H14N2O2S [M]+ 262.0776, found 262.0770.  
Ethyl 2-(2-((4-methoxybenzyl)thio)-5-methyl-4-oxo-3,4-dihydropyrimidin-1(2H)-
yl)acetate (32) 
 
 To a solution of sodium (210 mg, 9.15 mmol) in ethanol (15 mL) at reflux, was 
added 2-(4-methyoxybenzyl)thiothymine (1.2 g, 4.57 mmol) followed by ethyl 
bromoacetate (1.0 mL, 9.15 mmol). The reaction was stirred for 2 h. at reflux, then the 
solvent was evaporated under reduced pressure. The residue was dissolved in water (15 
mL) and extracted with a solution of 3:1 dichloromethane: methanol (2 x 60 mL). The 
organic layers were combined, dried over sodium sulfate, and evaporated under reduced 
pressure. The crude oil was washed with a solution of 1:1 ethyl acetate: hexanes (3 x 10 
mL), the washes were combined and evaporated under reduced pressure. The resultant 
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solid was suspended in ice cold ethyl acetate and the product was collected by filtration, 
yielding a pure white solid (612 mg, 38 %). 1H NMR (400 MHz, DMSO-d6) δ 7.62 (s, 1 H), 
7.34 (d, J = 8.7 Hz, 2 H), 6.88 (d, J = 8.7 Hz, 2 H), 4.76 (s, 2 H), 4.37 (s, 2 H), 4.17 (q, J = 7.1, 
2 H), 3.73 (s, 3 H), 1.82 (s, 3 H), 1.18 (t, J = 7.1, 3 H). 13C NMR (400 MHz, DMSO) δ 167.9, 
167.5, 159.2, 142.1, 130.9, 128.6, 117.4, 114.4, 62.2, 55.5, 52.8, 34.9, 14.4, 13.8. HRMS 
(EI) calculate for C17H20N2O4S [M]+ 348.1144, found 348.1145. 
2-(2-((4-Methoxybenzyl)thio)-5-methyl-4-oxo-3,4-dihydropyrimidin-1(2H)-yl)acetic 
acid (33) 
 
 To a solution of 32 (250 mg, 0.72 mmol) dissolved in methanol (2.2 mL) and 
tetrahydrofuran (5 mL) was added 0.72 mL of 2 M lithium hydroxide, then the solution 
was stirred for 15 min. The solvent was evaporated under reduced pressure, then the 
residue was dissolved in 5 mL water and the solution was acidified with 2 M hydrochloric 
acid. The resultant precipitate was filtered and washed with cold ethyl acetate and diethyl 
ether which yielded a pure white solid (185 mg, 0.38 mmol, 80 %). 1H NMR (400 MHz, 
DMSO-d6) δ 13.53 (s, 1 H), 7.62 (s, 1 H), 7.34 (d, J = 8.4 Hz, 2 H), 6.88 (d, J = 8.4 Hz, 2 H), 
4.64 (s, 2 H), 4.37 (s, 2 H), 3.73 (s, 2 H), 1.82 (s, 3 H). 13C NMR (400 MHz, DMSO) δ 168.9, 
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167.9, 161.6, 159.1, 142.3, 130.9, 128.7, 117.5, 114.4, 55.6, 52.9, 34.8, 13.8. HRMS (EI) 
calculated for C15H16N2O4S [M]+ 320.0831, found 320.0828. 
 
Scheme 4.6. Synthesis of Fmoc-thiothymine PNA monomer (37)  
Methyl-N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)glycinate 
hydrochloride (35) 
 
 To a suspension of 34 (1.00 g, 4.87 mmol) and Fmoc-succinimide (1.80 g, 5.36 
mmol) in 16 mL dioxane was added a solution of sodium bicarbonate (1.23 g, 14.61 mmol) 
in 20 mL water, then the resulting solution was stirred for 50 min. The solution was diluted 
with 60 mL water, then the white precipitate was extracted with dichloromethane (3 x 50 
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mL). The dichloromethane layers were combined, dried over sodium sulfate, filtered, and 
the resultant solution was acidified with ethereal hydrochloric acid. The solution was 
cooled overnight and the resultant precipitate filtered to yield the product (35) as a pure 
white solid (432 mg, 23 %). 1H NMR (400 MHz, DMSO-d6) δ 9.21 (br s, 2H), 7.90 (d, J = 7.5 
Hz, 2H), 7.70 (d, J = 7.5 Hz, 2H), 7.54 (t, J = 5.1, 1H), 7.42 (t, J = 7.5 Hz, 2H), 7.34 (t, J = 7.5 
Hz, 2H), 4.34 (d, J = 6.7 Hz, 2H), 4.23 (t, J = 6.8, 1H), 3.96 (s, 2H), 3.74 (s, 3H), 3.33 
(overlapping with water), 3.00 (t, J = 6.4 Hz, 2H). 13C NMR (400 MHz, DMSO-d6) δ 167.9, 
156.8, 144.3, 141.2, 128.1, 127.6, 125.6, 120.6, 66.1, 55.4, 53.0, 47.3, 47.1, 37.3. This 
closely corresponded to 1H NMR spectra previously reported in the literature.6 
Methyl-N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4-
methoxybenzyl)thio)-5-methyl-4-oxopyrimidin-1(4H)-yl)acetyl) glycinate (36) 
 
 To a solution of 33 (280 mg, 0.87 mmol) in 7 mL dimethylformamide at 0 oC was 
added HBTU (338 mg, 0.89 mmol) and diisopropylethylamine (0.48 mL, 1.55 mmol) and 
stirred for 2 min., then 35 (375 mg, 0.96 mmol) was added to the reaction and the mixture 
was stirred for 2 h., then allowed to warm to room temperature. The reaction mixture 
was diluted with 15 mL ethyl acetate, poured into 40 mL water, then extracted with ethyl 
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acetate (3 x 20 mL). The organic layers were combined, washed with 5 % citric acid in 
water (20 mL), saturated sodium bicarbonate (20 mL), and brine (20 mL), then dried over 
sodium sulfate, filtered, after which the solvent was evaporated under reduced pressure. 
This yielded a crude orange oil which was purified by column chromatography on silica 
gel (1 % methanol-dichloromethane to 5 % methanol-dichloromethane) to yield 
compound 36 as a pure white solid (312 mg, 0.48mmol, 55 %) HRMS (ESI) calculated for 
C35H36N4O7SNa [M+Na]+ 679.2202, found 679.2205.  
N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((4-
methoxybenzyl)thio)-5-methyl-4-oxopyrimidin-1(4H)-yl)acetyl)glycine (37) 
 
 To a solution of 36 (312 mg, 0.48 mmol) in 8 mL tetrahydrofuran at 0 OC was added 
8 mL 2 M lithium hydroxide then the solution was stirred for 30 min. The reaction was 
neutralized with 2 M hydrochloric acid then the solvent was evaporated under reduced 
pressure. The residue was suspended in 10 mL ice cold water and the resultant precipitate 
was collected by filtration. The solid was suspended in cold dichloromethane, then the 
product was collected by filtration to yield the PNA monomer (37) as a pure white solid 
(126 mg, 20 mmol, 41 %) 1H NMR (400 MHz, DMSO-d6) δ 8.06 (m, 1H), 7.89 (d, J = , 2H), 
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7.67 (m, 2H), 7.43-7.27 (m, 7H), 6.80 (d, J = , 2H), 4.70 (s, 2H), 4.28 (s, 2H), 4.16 (s, 2H), 
3.69 (s, 3H), 3.64 (s, 2H), 3.59 (s, 1H), 3.38 (m, 2H), 3.15 (m, 2H), 1.73 (s, 3H). 13C NMR 
(400 MHz, DMSO) δ 170.2, 168.2, 166.8, 162.0, 159.0, 156.5, 144.4, 142.5, 141.1, 130.8, 
129.4, 128.8, 128.1, 127.8, 127.6, 125.9, 121.9, 120.5, 117.1, 114.3, 66.0, 55.5, 53.5, 53.0, 
48.4, 47.2, 38.4, 34.9, 13.7. HRMS (ESI) calculated for C34H34N4O7SNa [M+Na]+ 665.2046, 
found 665.2030.  
Oligomer synthesis 
 The PNA oligomers were synthesized using an ABI 433A peptide synthesizer 
manufactured by Perkin Elmer Applied Biosystems. Oligomerization was carried out using 
newly synthesized SU and ST monomers, commercially available PNA monomers: Fmoc-
A(Bhoc)-AEG-OH, Fmoc-G(Bhoc)-AEG-OH, and Fmoc-C(Bhoc)-AEG-OH (purchased from 
PolyOrg, Inc.), and Nα-Fmoc-Nε-Boc-Lysine (purchased from Chem-Impex Int’l Inc.), using 
standard FastMoc oligomerization methods for Fmoc-based solid-phase peptide 
synthesis. Fmoc-RAM-PS was used as a solid support resin preloaded with lysine at 0.057 
mmol/g. Synthesis was carried out on a 5.0 μmol scale. Monomers were prepared at a 
concentration of 25 μmol dissolved in 110 μL. Solutions of 0.4 M diisopropylethylamine 
in N-methyl-2-pyrrolidone (NMP) and 0.19 M HBTU in NMP were prepared for monomer 
coupling. Fmoc deprotection was performed using a solution of 20 % 4-methylpiperidine 
in dimethylformamide. Unreacted terminal amino groups were capped with acetic 
anhydride, using a solution of 1:25:25 acetic anhydride: pyridine: NMP. Following 
automated synthesis, the resin was treated with a solution of 95 % trifluoroacetic acid 
and 5 % triethylsilane to cleave the oligomer from the resin and remove the protecting 
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group from the nucleobases (Bhoc) and amino group (Boc). The solvent was then 
evaporated under a nitrogen stream, the resultant residue was washed twice with cold 
ether, dissolved in a solution of 0.05% trifluoroacetic acid in water then purified by 
reverse-phase HPLC. Reverse-phase HPLC was performed on an Agilent Microsorb-MV 
100-5 C18 250 x 4.6 mm column heated to 50 oC. The purified PNA oligomer was eluted 
using a gradient (water/0.1 % trifluoroacetic acid to acetonitrile/0.1 % trifluoroacetic acid) 
over 60 min.  
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